Koninklijke DSM NV (KDSKF.PK)

KDSKF.PK on OTC Markets Group - US Other OTC and Grey Market

24 Jul 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for KDSKF.PK


Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in health, nutrition and materials. The Company operates in segments: Nutrition, Performance Materials, Polymer Intermediates, Innovation Center and Corporate Activities. DSM Nutritional Products is the supplier of essential nutrients, such as vitamins,... (more)


Beta: 0.91
Market Cap(Mil.): €9,464.94
Shares Outstanding(Mil.): 181.43
Dividend: 1.10
Yield (%): 3.16


  KDSKF.PK Industry Sector
P/E (TTM): 102.02 32.45 18.70
EPS (TTM): 0.51 -- --
ROI: 1.34 5.84 13.74
ROE: 1.51 6.65 15.45
Search Stocks

CORRECTED-EU mergers and takeovers (July 23)

BRUSSELS, July 23 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

24 Jul 2015

EU clears CVC purchase of majority stake in DSM chemical units

July 23 - European antitrust regulators said on Thursday it approved CVC Capital Partners' acquisition of a majority stake in two chemicals subsidiaries of Dutch food and dietary supplements maker DSM.

23 Jul 2015

EU mergers and takeovers (July 22)

BRUSSELS, July 20 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

22 Jul 2015

BRIEF-DSM and Medday to produce pharmaceutical grade D-Biotin

* Medday and DSM announce a partnership to produce pharmaceutical grade D-Biotin to treat progressive multiple sclerosis

17 Jun 2015

BRIEF-Koninklijke DSM announces joint venture with Sobisco in India

* Announces joint venture with Sobisco to produce fortified foods and beverages for Eastern India

05 Jun 2015

UPDATE 2-Top EU companies urge drastic cuts in greenhouse gas emissions

* Want tough action from Paris U.N. summit in December (Updates with quotes from Kerry, Fabius, DSM)

21 May 2015

BRIEF-DSM finalizes sale of DSM Synres to Standard Investment

* DSM Synres realizes sales of about 50 mln euro with around 80 employees

02 Apr 2015

UPDATE 1-DSM sells 65 percent stake in chemicals to CVC for at least 300 mln euros

* Deal will refocus company on less cyclical nutrition businesses

16 Mar 2015

DSM sells polymers, resins stake to CVC for at least 300 mln euros

AMSTERDAM, March 16 - Dutch supplements maker DSM said on Monday it will sell a 65 percent stake in two of its chemicals subsidiaries to CVC Capital Partners for at least 300 million euros ($316 million) in cash.

16 Mar 2015

BRIEF-DSM says CVC to invest in polymer intermediates, composite resins units

* Dsm and cvc announce partnership for polymer intermediates and composite resins

16 Mar 2015

Earnings vs. Estimates

Search Stocks